Medicine
Kedrab 150 IU/mL injection
Kedrab 150 IU/mL injection is a prescription medicine containing Human rabies virus immune globulin for intramuscular use, marketed by Kedrion Biopharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store KEDRAB at 2-8 °C (36-46 °F). DO NOT FREEZE. Use within one month after…
Key facts
- Active ingredient (INN)
- Human rabies virus immune globulin
- Brand
- Kedrab
- Strength
- 150 IU/mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 1 vial
- Marketing authorisation holder
- Kedrion Biopharma
- Manufacturer
- Kedrion Biopharma
- Origin register
- US FDA, United States
- Storage
- Store KEDRAB at 2-8 °C (36-46 °F). DO NOT FREEZE. Use within one month after removal from refrigeration. Do not return to refrigeration. KEDRAB may be stored at room temperatures not exceeding 25 °C (77 °F) for up to one month.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 November 2017
- Identifiers
- RxCUI 1652827, 1652833, 1992536 +1DailyMed set ID 53f2a23b-c479-4c24-8cab-ee7a33a2633eNDC 76125-150Application BLA125613
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, glass in 1 box / 2 mL in 1 vial, glass | 76125-150-02 | Kedrion Biopharma | 8 November 2017 |
| 1 vial, glass in 1 box / 10 mL in 1 vial, glass | 76125-150-10 | Kedrion Biopharma | 8 November 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Human rabies virus immune globulin
Clinical summary
Human rabies virus immune globulin is a prescription medicine. It is available as injection for intramuscular and infiltration use. MedsAcross supplies Human rabies virus immune globulin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Human rabies virus immune globulinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KEDRAB prescribing information (Kedrion Biopharma) · U.S. National Library of Medicine, DailyMed
Need Kedrab 150 IU/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.